HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carl F Beyer Selected Research

cevipabulin

4/2008TTI-237: a novel microtubule-active compound with in vivo antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carl F Beyer Research Topics

Disease

4Neoplasms (Cancer)
04/2008 - 01/2002
2Carcinoma (Carcinomatosis)
04/2008 - 03/2005
2Leukemia
01/2002 - 01/2002
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2002 - 01/2002
1Glioblastoma (Glioblastoma Multiforme)
04/2008
1Breast Neoplasms (Breast Cancer)
03/2005

Drug/Important Bio-Agent (IBA)

4CalicheamicinsIBA
03/2005 - 01/2002
2CarbohydratesIBA
03/2005 - 01/2002
2AmidesIBA
03/2005 - 03/2005
2Anti-Bacterial Agents (Antibiotics)IBA
03/2005 - 01/2002
2AntigensIBA
03/2005 - 03/2005
1Paclitaxel (Taxol)FDA LinkGeneric
04/2008
1cevipabulinIBA
04/2008
1ColchicineFDA LinkGeneric
04/2008
1Vincristine (Oncovin)FDA LinkGeneric
04/2008
1Immunoglobulin G (IgG)IBA
03/2005
1Monoclonal AntibodiesIBA
03/2005
1Cisplatin (Platino)FDA LinkGeneric
03/2005
1hCTMO1-calicheamicinIBA
03/2005
1Gemtuzumab (Mylotarg)FDA Link
01/2002